|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Genoptix, Inc.
| | | Phone: | (760) 268-6200 | Fax: | (760) 268-6201 | Year Established: | 1999 | Ticker: | GXDX | Exchange: | NASDAQ | Main Contact: | Joseph M. Limber, President & CEO | | Other Contacts: | Derek Lyle, MD, FCAP, CMO Mark E. Spring, CFO Brett K.E. Lund, JD, MBA, CLO
| | Company Description | Genoptix provides Personalized Medicine Services through its CLIA and CAP certified laboratory to hematologists and oncologists in order to resolve management dilemmas in the treatment of blood and bone marrow malignancies. Personalized Medicine Services combines proprietary and exclusive tests with advanced clinical techniques to provide comprehensive evaluation to individual patients.
On Oct. 21. 2018, NeoGenomics announced an agreement to acquire Genoptix, Inc. for $125 million in cash and 1 million shares of NeoGenomics common stock. | |
|
|
|
|
|